Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,072 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation.
Kato M, Ishida H, Koh K, Inagaki J, Kato K, Goto H, Kaneko T, Cho Y, Hashii Y, Kurosawa H, Takita J, Hamamoto K, Inoue M, Sawada A, Suzuki R, Kato K. Kato M, et al. Among authors: kurosawa h. Pediatr Blood Cancer. 2015 Oct;62(10):1844-50. doi: 10.1002/pbc.25602. Epub 2015 Jun 5. Pediatr Blood Cancer. 2015. PMID: 26053959
Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan.
Yabe M, Ohtsuka Y, Watanabe K, Inagaki J, Yoshida N, Sakashita K, Kakuda H, Yabe H, Kurosawa H, Kudo K, Manabe A; Japanese Pediatric Myelodysplastic Syndrome Study Group. Yabe M, et al. Among authors: kurosawa h. Int J Hematol. 2015 Feb;101(2):184-90. doi: 10.1007/s12185-014-1715-7. Epub 2014 Dec 11. Int J Hematol. 2015. PMID: 25504334
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
Muramatsu H, Kojima S, Yoshimi A, Atsuta Y, Kato K, Nagatoshi Y, Inoue M, Koike K, Kawase T, Ito M, Kurosawa H, Tanizawa A, Tono C, Hamamoto K, Hotta N, Watanabe A, Morishima Y, Kawa K, Shimada H. Muramatsu H, et al. Among authors: kurosawa h. Biol Blood Marrow Transplant. 2010 Feb;16(2):231-8. doi: 10.1016/j.bbmt.2009.09.022. Epub 2009 Sep 30. Biol Blood Marrow Transplant. 2010. PMID: 19800016 Free article.
A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
Yabe M, Sako M, Yabe H, Osugi Y, Kurosawa H, Nara T, Tokuyama M, Adachi S, Kobayashi C, Yanagimachi M, Ohtsuka Y, Nakazawa Y, Ogawa C, Manabe A, Kojima S, Nakahata T; Japanese Childhood MDS Study Group. Yabe M, et al. Among authors: kurosawa h. Pediatr Transplant. 2008 Dec;12(8):862-7. doi: 10.1111/j.1399-3046.2008.00931.x. Epub 2008 Apr 6. Pediatr Transplant. 2008. PMID: 18397212
Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Kurosawa H, Tanizawa A, Muramatsu H, Tono C, Watanabe A, Shima H, Ito M, Yuza Y, Hamamoto K, Hotta N, Okada M, Saito AM, Manabe A, Mizutani S, Adachi S, Horibe K, Ishii E, Shimada H. Kurosawa H, et al. Pediatr Blood Cancer. 2018 Dec;65(12):e27368. doi: 10.1002/pbc.27368. Epub 2018 Aug 7. Pediatr Blood Cancer. 2018. PMID: 30084127 Clinical Trial.
1,072 results